Pharmaceutical Technology5 天
Benzgalantamine DR by AlphaCognition for Traumatic Brain Injury: Likelihood of Approval
Benzgalantamine DR is under clinical development by AlphaCognition and currently in Phase I for Traumatic Brain Injury.